Maxlinear (MXL) EBIAT (2016 - 2025)
Maxlinear (MXL) has disclosed EBIAT for 16 consecutive years, with -$14.9 million as the latest value for Q4 2025.
- On a quarterly basis, EBIAT rose 74.24% to -$14.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$136.7 million, a 44.26% increase, with the full-year FY2025 number at -$136.7 million, up 44.26% from a year prior.
- EBIAT was -$14.9 million for Q4 2025 at Maxlinear, up from -$45.5 million in the prior quarter.
- In the past five years, EBIAT ranged from a high of $33.6 million in Q1 2022 to a low of -$75.8 million in Q3 2024.
- A 5-year average of -$14.4 million and a median of -$9.6 million in 2023 define the central range for EBIAT.
- Peak YoY movement for EBIAT: surged 4260.98% in 2022, then tumbled 858.51% in 2024.
- Maxlinear's EBIAT stood at $28.2 million in 2021, then grew by 10.06% to $31.0 million in 2022, then tumbled by 224.14% to -$38.5 million in 2023, then plummeted by 50.23% to -$57.8 million in 2024, then skyrocketed by 74.24% to -$14.9 million in 2025.
- Per Business Quant, the three most recent readings for MXL's EBIAT are -$14.9 million (Q4 2025), -$45.5 million (Q3 2025), and -$26.6 million (Q2 2025).